It looks like something’s cooking. It has the part regarding Leo’s salary and performance plan…
“…with a maximum value of up to $35.0 million, contingent upon the achievement of certain market capitalization, licensing revenue and clinical trial performance goals, and (ii) cash awards with a maximum value of up to $14.0 million, contingent upon the achievement of certain market capitalization and licensing revenue goals.”
…and compensation awa4ds for directors.
There’s no protection for Leo if the stock doesn’t perform.
“Of all tyrannies, a tyranny sincerely exercised for the good of its victims may be the most oppressive...those who torment us for our own good will torment us without end for they do so with the approval of their own conscience.” C.S. Lewis